ITCI |
Intra-Cellular Therapies, Inc. |
Nov 12, 2024 |
9 |
-$2.45M |
4 |
Nov 14, 2024 |
President |
ITCI |
Intra-Cellular Therapies, Inc. |
Mar 7, 2024 |
6 |
-$1.35M |
4 |
Mar 11, 2024 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Mar 6, 2024 |
2 |
$0 |
4 |
Mar 8, 2024 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Mar 1, 2024 |
1 |
$0 |
4 |
Mar 5, 2024 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Feb 23, 2024 |
5 |
-$550K |
4 |
Feb 27, 2024 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Feb 1, 2024 |
3 |
-$788K |
4 |
Feb 5, 2024 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Jan 11, 2024 |
7 |
-$2.66M |
4 |
Jan 12, 2024 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Nov 13, 2023 |
6 |
-$2.02M |
4 |
Nov 14, 2023 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Mar 9, 2023 |
7 |
-$1.05M |
4 |
Mar 13, 2023 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Mar 6, 2023 |
1 |
$0 |
4 |
Mar 8, 2023 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Feb 23, 2023 |
3 |
-$372K |
4 |
Feb 27, 2023 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Feb 18, 2023 |
6 |
-$522K |
4 |
Feb 22, 2023 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Dec 1, 2022 |
4 |
-$1.91M |
4 |
Dec 2, 2022 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Mar 10, 2022 |
2 |
$0 |
4 |
Mar 14, 2022 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Feb 23, 2022 |
4 |
-$411K |
4 |
Feb 25, 2022 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Feb 18, 2022 |
4 |
-$617K |
4 |
Feb 23, 2022 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Jan 8, 2022 |
5 |
-$801K |
4 |
Jan 11, 2022 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Dec 21, 2021 |
11 |
-$5.51M |
4 |
Dec 23, 2021 |
EVP and General Counsel |
ITCI |
Intra-Cellular Therapies, Inc. |
Jan 4, 2016 |
1 |
$0 |
4/A |
Jul 7, 2023 |
EVP and General Counsel |